financial pacific - economic insights by george magnus (third party)

UBS Investment Research

Morning Expresso - United States

Tuesday 13 September 2011

Global Equity Research

Americas

Equity Strategy

Market Comment

13 September 2011

www.ubs.com/investmentresearch

U.S. Equity Product Management

212-713-2400

Morning Expresso

This report has been prepared by UBS Securities LLC ANALYST CERTIFICATION AND REQUIRED DISCLOSURES BEGIN ON PAGE 35. UK Takeover Panel Disclosure: UBS Limited is acting as joint financial advisor to Autonomy Corp Plc in respect of the announced recommended offer from Hewlett Packard Co UBS does and seeks to do business with companies covered in its research reports. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single factor in making their investment decision.

ab

Morning Expresso - United States 13 September 2011

UBS 2

Morning Meeting Agenda Coca-Cola Ent. Rating: Buy Target: US$30.00 Price: US$25.52 RIC: CCE.N Prior: Neutral Prior: Unchanged Mkt Cap: US$8.45bn BBG: CCE US

Soft Drinks Analyst: Kaumil S. Gajrawala Tel: +1-212-713 9318

Concerns are Not Reality – Upgrade to Buy Upgrade to Buy – Price Target $30 (~18% upside) Despite continuing to deliver results that outpace our coverage, CCE has under performed its

peers (300bps in last month). We believe this is unjustified, and are upgrading CCE shares to Buy. In this note, we address key concerns such as 1) health of the consumer, 2) commodities, 3) macro concerns in Europe, and 4) proposed tax in France. We are confident in CCE's ability to manage these issues.

Concerns Affecting CCE are not Warranted Four major concerns are weighing on the perceived operational ability of CCE. First, consumer health. Historically, consumer health hasn’t weighed too heavily on CCE and we think they can deliver in today’s environment. Second, worsening COGS. Since the 2Q call, most major input prices have fallen. Third, European instability. CCE’s operations have held up to disruptions thus far and are not correlated to GDP. Fourth, the proposed soda tax in France. We believe CCE can passthrough taxes, if enacted, and volume impact will be minimal.

CCE Stronger than Peers yet Shares have Underperformed We remain confident that the Company can deliver above longer-term trend growth targets in 2011. CCE shares have underperformed their peer group over the last three months, despite delivering better organic growth and guidance. We believe this is irrational and that CCE shares are a compelling opportunity at these levels. Our 12EPSe is $2.37 from $2.39 on increased buyback but FX headwinds.

Valuation: Upgrading to Buy; Price Target $30 Our $30 PT is 12.5x our 2012 EPS estimate of $2.37. (~9x EV/NTM EBITDA). Notes:

Source: The content presented above reflects a front page summary of UBS Research content, UBS estimates based on a share price of US$25.52 on 12 Sep 2011 18:42 EDT Outdoor Advertising

Advertising Analyst: Jaime Morris, CFA, CPA Tel: +1-212-713 9319

Outdoor: Cautious on All Things Local We are initiating coverage of the out-of-home sector with a cautious view Our cautious view is driven by: 1) macro concerns, particularly on the

local ad front, which accounts for ~70% of outdoor advertising; 2) increasing local market media fragmentation slowly taking share of outdoor advertising dollars and pressuring costs per thousand (CPMs), and 3) fears that digital is creating overcapacity in the industry.

We rate Lamar Sell with a $16 price target Despite the 53% decline in LAMR shares year to date, we think there is further risk to the downside. We expect macroeconomic pressures, particularly for Lamar’s small, local customer base (80% of revenue), and local market media fragmentation to continue. Moreover, we think digital is creating overcapacity, particularly in Lamar’s smaller markets, which is weighing on occupancy and pricing.

We rate Clear Channel Outdoor Neutral with an $11 price target We prefer Clear Channel’s (CCO) larger market exposure and more diversified national/ local revenue stream (40% national vs. 20% for LAMR). However, we think CCO also faces macro headwinds and increasing secular pressures, and believe the parent company’s leverage (10.7x at 6/30/11) and potential impact on CCO will remain an overhang for the near to intermediate term.

Multiples below historical average, but we expect further compression The U.S.-based outdoor companies are trading at 7.9x our 2012E EBITDA, below their historical average of 10.8x and towards the lower end of a 6-15x range. However, given our expectation for slower top-line growth and muted margin expansion, we expect further compression from current levels.

Notes: Source: The content presented above reflects a front page summary of UBS Research content, UBS commentary as at 12 September 2011

Leisure and Lodging Report

Leisure Goods & Services Analyst: Robin M. Farley Tel: +1-212-713 2060

By Land or By Sea: Cruise Yield vs. Lodging RevPAR Performance Lodging more sensitive to macro shifts than cruise net yields Since 1998, lodging yield growth outperformed cruise yield growth in periods of

macro-economic growth and has underperformed cruise yields in macro declines. In that time frame, U.S. RevPAR has outperformed cruise industry net yields in periods of real YOY GDP growth and underperformed net yields in periods of real YOY GDP declines 35 of the last 54 quarters (since the beginning of 1998).

U.S. RevPAR yields have more room for recovery to peak When adjusted for foreign currency, cruise industry yields were 7-8% below peak at the end of 2010, and as we expect yields to increase about 2% on a constant FX basis in 2011, we believe cruise yields could have 5-6% points of room for recovery back to 2008 levels by the end of 2011 vs. 7-8% points of room for recovery back to peak levels for U.S. RevPAR

Cruise Yields Offer More Downside Protection As They Are More Elastic Lodging is driven by corporate activity, so it tends to be more price inelastic. However, cruise line yields have historically been more price elastic, as they are driven by leisure expenditures, so to the extent that a recovery is muted and there are macro concerns, cruise line yields could potentially be preferable as they offer downside protection and cruise lines would also be likely benefit more at the EPS line from a pull back in fuel price in a declining macro environment. Preferred names are Starwood and Carnival.


http://research.ibb.ubs.com/doc/200267945?doc=200267945




UBS 3

HCA Rating: Buy Target: US$33.00 Price: US$18.40 RIC: HCA.N Prior: Unchanged Prior: Unchanged Mkt Cap: US$9.83bn BBG: HCA US

Healthcare Providers Analyst: Justin Lake, CFA Tel: +1-212-713 2765

Update Mixed But Quarter On Plan Deep dive shows several factors impacting Q2, w/ half expected to continue While declines in case mix index singled out as culprit in Q2, HCA

analysis shows acuity only about 40% of the $74m problem w/ changes in regulatory environment (72 hour rule, CT scans) 40% and cost report headwinds 20%. Much of headwind indicated as one-time in nature ($37m / 50%), although $25m mix impact may accelerate given 3Q decline before easier comps help in Q4 and beyond. While geography not main issue, half of acuity change related to cardiac surgery decline.

While Q3 volumes looking strong, pricing yields continue to be pressured Based on the first two months of the quarter, same store adj. admits were strong at up 4.3% YoY (THC up 2.5%). Pricing, however, was well below company's +1% expectation at -0.9% cash revenue per adj. admit (Medicare CMI down -2.0%), yielding total cash revenues up 3.4% YoY (4.6% in Q2). Cost side was better than advertised at +0.3% vs. +1.0% expectation, leaving HCA on-plan for July/Aug from EBITDA perspective (flat to down slightly - UBS $1,362m, up 0.3% YoY).

Mixed bag but we expect relief as "worst-case" co specific issues dismissed Tough pricing comps subside over next few quarters & cost mgmt will be key heading into 2012. Q3 payer mix provided w/ Medicaid admits up 5.8% (5.5% for THC), Medicare up 5.6%, commercial +0.9% & uninsured +10.1% (+10.6% Q2). 2011/2012 HealthONE accretion (10/31 close) is $0.01-$0.02/$0.15-$0.18. Interest expense tailwind meaningful at $358m annually or $0.33 incremental in 2012.

Valuation: Buy Rating, $33 Price Target $33 PT based on target EV/EBITDA multiple of ~7.25x our 2012 est of $6,159m. Notes:

Source: The content presented above reflects a front page summary of UBS Research content, UBS estimates based on a share price of US$18.40 on 12 Sep 2011 18:42 EST



UBS 4

MACRO AND STRATEGY RESEARCH US Daily Economic Comment

Economist: Maury N. Harris Tel: +1-212-713 2472

Updates on small firms and consumers Preview: Data on small biz, consumer, Federal budget, import prices Tuesday’s data will give updates on small business, import prices, and the

Federal budget, as well as a little more information on consumer sentiment and spending. The NFIB small business optimism index for Aug will be reported. Labor market details have already been released: A net 5% of firms planned to raise

employment—the best reading, apart from Dec 2010, since before the recession. For Aug, we forecast some softening in import price pressures. Import prices probably fell 2.0% on energy. Prices excl. fuels likely edged up 0.1%, with

declines in auto prices and only a modest increase for nonenergy commodities. In the IBD/TIPP economic optimism measure, declines have been led by the economic outlook and by assessments of economic policy. The

President’s jobs speech does not appear to have caused a turnaround in the daily Rasmussen index.Store sales figures are holding up but were likely distorted by the hurricane.

The Congressional Budget Office estimates an Aug budget deficit $41B larger than last year, with $28B of the widening caused by shifts in the timing of outlays.Manpower hiring plans broadly track growth in payrolls. However, they usually lag turning points in employment trends—limiting their usefulness (see chart).

Review: The other shoe drops (on the jobs bil.). Fisher argues for … The White House released its plans to pay for the new job initiatives: limiting itemized deductions; treating carried interest as ordinary income; and taxing the petroleum industry and corporate jets. Unsurprisingly (FOMC dissenter) Dallas Fed Pres Fisher remains sceptical of the need for further Fed easing.


Economic Insights - By George

Economist: George Magnus Tel: +44-20-7568 3322

Agenda - Setting at a Time of Crisis Now that the economic and market bungee jump out of the 2009 abyss is over, there is growing evidence that economic growth in the West, but

also beyond, has slowed down, possibly threatening to turn into a contraction. The stall in growth this year was destined to happen, and especially as governments have now all fallen into line behind austerity. As is often pointed out (see, for example, Developed Markets and Deleveraging: Dating Japan, Economic Insights, 23rd June 2011), the levels of economic activity by and large everywhere remain quite low or depressed relative to where we were at the last cycle peak in Q1, 2008. This means that if there is a ‘recession’ or a ‘double dip’ in the next several months, it would actually be neither, but a continuation of the recession that began three years ago.

Seen from this point of view, the contemporary economic policy discussion agenda is facile. Fixing public finance is of course necessary, especially the burden of our age-related spending liabilities is starting to weigh, and before it becomes really heavy from about 2018-2020. But few politicians acknowledge the limitations of what I have called ‘Deficit Attention Disorder’ (The Convulsions of Political Economy, Economic Insights, 16th August 2011).

The private sector has no choice but to deleverage, exacerbating the economic impact of the loss of past growth drivers. Untimely financial attrition in the public sector, therefore, is going to add to the economic predicament. Framing the agenda as a public finance issue only isn’t going to produce economic stability and a return to sustainable growth. The problem needs to be considered more widely, encompassing our system’s lack of capacity to create jobs and strengthen income formation. And several major governments retain the ability to structure public finance in ways that can help both, while preserving a credible long-run programme to lower the public debt burden. President Obama recently proposed the former but the US lacks the latter, while the UK and others have the emphasis the other way round.

Source: The content presented above reflects a front page summary of UBS Research content, UBS commentary as at 12 September 2011

European Equity Strategy

Strategist: Karen Olney, CFA Tel: +44-20-7568 8944

Switzerland: Still be ‘haven’? SNB stands in way of a strong CHF The SNB ‘will no longer tolerate’ a EURCHF below 1.20. Our Economist Reto Huenerwadel shows the

Purchasing Power Parity (PPP) fair value at EURCHF 1.34. He agrees with the SNB that the CHF is overvalued so thinks near term there is upside risk. FX analyst Beat Siegenthaler flags two risks: (i) buying euros could lead to big losses and (ii) inflation. But, saving the exporters took priority.

Country score-card: Switzerland in only 12th place. A ‘haven’ for some… The Swiss franc was a successful ‘haven’. But, a pain for many: 2011E earnings momentum plunged to a ten-year low, dragging Switzerland down in our score-card. Bottom-up consensus tells us that 2011E earnings growth for Switzerland will be negative, when consensus for Europe is still at +8.0%.

Do you buy Switzerland after announcement? Most say yes. We asked investors. The response was split: about 65%, largely those that were hedged, said they would increase exposure on an earnings turn-around that may not yet be in analysts’ numbers. We saw interest in pharmaceuticals, luxury goods and the beaten up cyclicals. Most thought Food & Beverage was too expensive. Switzerland will likely improve in its rank as EPS turns. We still like core Europe.

Company data & country chart-book Stocks: See the fall in earnings momentum over 1, 3 and 6 months, along with performance and discount to 10-year PE. Companies like Lonza, Actelion, Adecco and Novartis are examples where price is down more than EPS and are at a large PE discount. Analysts’ CHF assumptions for 2012.


http://research.ibb.ubs.com/servlet/SrchDoc/423233.pdf?doc=423233&f=sep11/xrm45220.pdf

http://research.ibb.ubs.com/servlet/SrchDoc/423224.pdf?doc=423224

http://research.ibb.ubs.com/servlet/SrchDoc/423218.pdf?doc=423218


UBS 5

Global Risk Radar

Strategist: Jeffrey Palma Tel: +1-203-719 1135

Risk appetite dips again, remains low Risk Appetite Indicator falls further The UBS Equity Risk Appetite Indicator decreased last week to -2.21 as of Friday’s close versus -1.87 the week

prior, as the MSCI AC World Index decreased by 3.4%. This marks the fifth consecutive week that the Indicator has been hovering around -2.0. Equity option volatility component decreases The VIX Index increased to 38.5 from 33.9 the week prior, which contributed to the fall in risk

appetite. Equities positioning component falls The equities positioning component decreased as indicators were largely mixed. Among regions, Japan, US

and Emerging markets outperformed while Europe ex UK underperformed significantly. Defensives slightly outperformed Cyclicals. Credit & FX component also decreases The credit & FX component decreased as FX volatility increased. Interest rate swap spreads and US

corporate credit spreads widened, which also moved this component lower. Notes:


http://research.ibb.ubs.com/servlet/SrchDoc/200267901.pdf?doc=200267901&f=sep11/uea14739.pdf


UBS 6

GLOBAL SECTOR RESEARCH UBS Global I/O®:Telecom Equipment

Communications Technology Analyst: Gareth Jenkins Tel: +44-20-7567 3950

Feedback from China and India field trip Input: Meetings broadly encouraging for telecom equipment We held over 25 meetings in China and India, including all the leading telecom

operators, local equipment vendors, retailers, distributors and regulators. We came back broadly encouraged on the capex environment, stable competition in wireless infrastructure as well as no signs of a macro impact on handset growth.

Infrastructure: robust capex, network based differentiation, better mix Our meetings suggest a robust capex environment in China in H2 as well as stable spend in 2012 due to the emergence of network based differentiation. We believe a relatively more level playing field is likely in TD-LTE at China Mobile vs. TD-SCDMA, which is positive for Ericsson. In India, while there is greater focus on capital efficiency and hence overall capex may come down, we believe electronics spend is likely to remain healthy due to robust minutes growth and 3G upgrades.

Handsets: no macro slow-down seen; Nokia turnaround in low-end Our checks indicate no signs of a macro slowdown in handset volumes. The local vendors, particularly ZTE, are seen as doing well in China in smartphones, with Samsung and HTC leading among the tier-1 vendors and Nokia absent. However, the latter is seeing a material pick-up in the low-end in India driven by the new dual-SIM products and regaining market share from the local branded vendors.

Output: Stock conclusions Our meetings were generally supportive for Ericsson, which remains one of our most preferred names in infra. On the handset side, we came back encouraged on ZTE, Samsung and HTC as well as a turn-around in the low-end for Nokia.

Notes:




UBS 7

BASIC MATERIALS Steel Dynamics Rating: Neutral Target: US$13.00 Price: US$11.18 RIC: STLD.O Prior: Unchanged Prior: Unchanged Mkt Cap: US$2.44bn BBG: STLD US

Steel Analyst: Shneur Z. Gershuni, CFA Tel: +1-212-713 3974

STLD 3Q Guidance Misses Cons STLD Guides to $0.18-$0.22 3Q EPS, below UBSe $0.26 STLD guided to $0.18-$0.22 3Q EPS, below cons $0.29 and UBSe $0.26. On the 2Q

earnings call, CEO Keith Busse said he expected a 3Q EPS, “in the 30s.” Specifically, the company noted that weak sheet demand and pricing, combined with persistently high scrap prices, compressed margins.

Structural & Bar Relatively Strong- Scrap Segment Continues Struggle STLD noted that structural and bar margins should improve q/q, and we note that these products, specifically Wide-Flanged Beams and Merchant Bar, did not fall as sharply as more widely quoted HRC. STLD stated improved economic clarity and low inventories could lead to improved results in 4Q. STLD also noted steel prices and margins have begun to improve, in-line with our expectations following recent hikes. STLD guided Metals Recycling as “consistent” with 2Q, a disappointing quarter, we look for mgmt commentary on improvement opportunities.

NUE Read-Through We expect a negative reaction across our coverage to STLD demand/pricing commentary. NUE will also guide this week- expect similarly weak pricing and high scrap costs to pressure margins; we estimate 3Q EPS of $0.60 vs cons. $0.66. NUE has a slightly easier comp vs. 2Q due to weather outages earlier this Summer.

Valuation We lower 3Q EPS est. to $0.22 from $0.26 and ‘11 to $1.30 from $1.36 on lower steel prices. We maintain our EV/EBITDA multiple derived price target of $13.

Notes:

Source: The content presented above reflects a front page summary of UBS Research content, UBS estimates based on a share price of US$11.18 on 12 Sep 2011 18:42 EST



UBS 8

COMMUNICATION Online Recruitment

Internet Services Analyst: John Janedis, CFA Tel: +1-212-713 1064

Early 2012 Look Not Encouraging More Cautious on Online Recruitment (OR) Sector We are incrementally more cautious on the Online Recruitment sector given channel

checks/macro concerns and our belief that 2012 budgets will be under more pressure than we had previously expected and that this cycle will be shorter than trend. We are lowering our sector growth/estimates for DHX and MWW. We maintain our Neutral rating on DHX and Buy rating on MWW on valuation.

Lowering Online Recruitment Sector Growth Estimates We now forecast overall OR industry revenues to grow 3% in 2012 vs. our prior estimate of +16%. We now estimate dice.com (DHX’s Tech & Clearance vertical) to grow 10% in 2012 (previously +16%) and MWW revenues to grow +2% in 2012 (previously +10%). Print should continue to lose share to the online players, and we forecast 2012 print help wanted growth of -7%.

Adjusting Estimates & Price Targets We are lowering our 2012 and beyond estimates to reflect our slower growth assumptions and lowering our price targets for DHX and MWW (details in table below and following pages). We maintain our Neutral rating on DHX with a $10 price target (vs. prior $15), and lowered our PT on buy rated MWW to $11 (prior $18).

Valuation Based on our revised estimates, DHX is trading at 16.8x and 7.6x our 2012 P/E and EV/EBITDA, while MWW is trading at 17.0x and 3.9x our 2012 P/E and EV/EBITDA, respectively.

Notes:




UBS 9

CONSUMER Starbucks Rating: Buy Target: US$47.00 Price: US$37.68 RIC: SBUX.O Prior: Unchanged Prior: Unchanged Mkt Cap: US$28.2bn BBG: SBUX US

Restaurants Analyst: David Palmer Tel: +1-212-713 9315

Solid Demand Growth; Buy Same Store Sales Momentum On-Track for F4Q Based on our consumer panel data for the first two months of F4Q, we believe that Starbucks US

same store sales (SSS) momentum remains solid and we see upside to our 6% SSS estimate for F4Q. Quarter-to-date sales trends suggest that 6-7% SSS growth is possible if momentum holds up in September.

Significant Potential in Coffee at Home We continue to view company guidance regarding K-Cups as conservative and believe that K-Cups will be a meaningful source of EPS upside for the company in F2012 and F2013. We estimate that K-Cups, together with bagged coffee--which has been fully transitioned from Kraft (KFT, Buy)--could add $0.15+ to FY12E EPS.

Strong Net Cash Position With approximately $1.5 billion in net cash and over $1 billion per year in cash flow, we continue to see a tremendous opportunity for the company to pursue acquisitions (and presumably leverage on its retail distribution and consumer base), dividend increases, and/or share repurchases, even after a potential payout to Kraft for bagged coffee.

Valuation: Buy Rated; $47 PT Our PT is based on UBS VCAM and represents 23x calendar 2012E EPS. Notes:

Source: The content presented above reflects a front page summary of UBS Research content, UBS estimates based on a share price of US$37.68 on 12 Sep 2011 16:15 EDT

Airlines & OTAs

Airlines Analyst: Kevin Crissey Tel: +1-212-713 3562

Short Interest Update Airlines: Covering Delta, shorting LUV & UAL In the second half of August, shorting and covering of the airline names was mostly uneventful as

share prices rose modestly. After seeing a 14% increase in the first half of Aug, DAL’s short interest declined 5% in the August 31 reporting period as the share price improved 3%. Alternatively, short interest in shares of UAL increased 7% in the period as UAL’s share price improved 2%. Among the low-cost carriers, investors increased negative positions in Southwest Airlines as short interest in shares of LUV increased 11%, or by 2.2 million shares. In aggregate, share prices improved 1% for the airlines during the period. Year-to-date through August, the legacies have declined 36% and the low-cost carriers are down 27%.

Online travel agencies (OTAs): Shorting EXPE & PCLN The OTAs saw more shorting activity than did the airlines. Short interest for Expedia increased 21% in the back half of August as investors shorted 3.7 million shares. Short interest for PCLN shares increased 16% as the share price improved 5%. Shares of OWW saw some modest covering as short interest declined 7%, or by 200K shares. Overall, the OTAs saw their share prices improve 4% during the period and they are up 29% year-to-date through August.

Notes:


US Online Travel Agencies Sector Note

Airlines Analyst: Kevin Crissey Tel: +1-212-713 3562

U.S. website visitors decline 4% in August Online Travel Agencies (OTAs) – U.S. website visitor trends remain soft Unique visitors in the US to online travel agency websites declined 4% in

August following a 7% decline in July. While the 2010 y/y comps are still running in double digits (Aug’10 unique visitors up 12%), the trend of international visitor growth outpacing domestic appears to be intact again this month. Additionally, excluding the growth from visitors to Expedia’s Tripadvisor unit, US unique visitors to the OTAs would have declined 10% in August, similar to the 9% decline in July ex-Trip.

TripAdvisor visitors up 20% On the whole, US website traffic to Expedia declined 4% in August. However, TripAdvisor sites saw 20% visitor growth, whereas Expedia’s US web traffic fell 19%. US web traffic to Orbitz was down 10% in August, an improvement from the 20%ish declines in prior months. Priceline traffic was up 2%.

Thoughts on the OTAs From a travel bookings perspective we expect a continuation of trend for now. International hotel bookings will be the growth story and domestic air bookings will remain challenged. We prefer EXPE to PCLN as the TripAdvisor spin provides growth at a reasonable price.

Notes:






UBS 10

UBS Commodity Comment

Agriculture Analyst: Peter Hickson Tel: +852-2971 7564

Blame the Weather Man Corn steals the show yet again: the USDA meet the market Persistent hot dry weather took its toll on a relatively immature crop reducing yield

potential, according to the USDA today. US yields were trimmed to the low side of market expectations. While the bulk of the cuts to yields have been made, in our view, US areas remain too high and we anticipate further production cuts in Oct. Latin America is the focus for market participants searching for production upside.

Give a little, take a little on soybeans While yields were slightly up, most believe areas will be trimmed in the Oct WASDE. Corn seems to be the undisputed front runner in the battle for acres in Latin America; USDA forecast areas remain broadly unchanged in Brazil. Stock levels were above market expectations but only mask the tightening USDA soybean balances – the stock-to-use ratio will hit its lowest level since 2008/09.

Wheat and cotton keep the bears happy Global wheat production has improved markedly in Canada, the EU and the FSU, a bearish signal for the wheat market. US wheat export forecasts were reduced by the USDA, struggling to be competitive in global markets, primarily due to its faithful relationship to US corn prices. Cotton was faced with a more bearish outlook, with upward revisions to USDA global production estimates. Cotton stocks-to-use is now approaching the more comfortable level of 45%, from 40% in 2010/11.

3 month preferences We see corn (bullish) and soybeans (neutral) continuing to have the strongest outlook, followed by wheat (neutral/bearish) and cotton (bearish).




UBS 11

ENERGY Inergy L.P. Rating: Buy Target: US$31.00 Price: US$27.43 RIC: NRGY.N Prior: Neutral Prior: US$36.00 Mkt Cap: US$3.34bn BBG: NRGY US

Gas Utilities Analyst: Ronald J. Barone Tel: +1-212-713 3848

Upgrade to Buy on Attractive Yield We Expect Current Tough Fundamental Environment to Improve NRGY shares have underperformed due to ST weakness in its two primary

segments: propane retailing/distribution and midstream natural gas and NGL storage (each should comprise ~50% of FY12 EBITDA). In propane, high costs and consumer conservation have hurt results, while in nat gas storage, a flat price curve has been damaging. We do not expect propane prices to continue to increase, and we believe the nat gas curve will steepen in time. As such, and given Inergy’s 10%+ yield, we are moving to a Buy rating while lowering our price target from $36 to $31.

Business Simplification is a LT Positive but NT Headwind By combining its GP & LP units, Inergy eliminated IDRs and lowered its cost of equity. However, the NT result has been to push down distribution coverage to 0.8x-0.9x for FY11 and ~1.0x for FY12. While concerning, we believe the distribution is safe given projects coming online, and that today’s yield provides an attractive entry point.

Solid Business Execution Leaves Us Positively Inclined We believe propane margins have held up reasonably well given the high cost of propane (up 46% over last 12 mo). Nat gas storage fundamentals remain weak due to: 1) compressed seasonal storage spread environment; 2) subdued market volatility; 3) increased storage capacity in No. America; and 4) a surplus supply. In our view, these factors could begin to work themselves out over the next 18 mo.

Valuation: Buy Rating; PT Moves from $36 to $31 Our DDM-derived price target implies a 9.1% yield on our FY12e $2.82/unit distribution. Notes:


PAA Natural Gas Rating: Buy Target: US$22.50 Price: US$16.40 RIC: PNG.N Prior: Neutral Prior: Unchanged Mkt Cap: US$1.17bn BBG: PNG US

Pipelines Analyst: Ronald J. Barone Tel: +1-212-713 3848

Upgrading to Buy on Valuation Weak Industry Fundamentals Contribute to 32% Pullback, but… PNG owns and operates 2 salt caverns (in Louisiana), 1 depleted reservoir (in

Michigan) and natural gas storage fields with an aggregate capacity of 71 billion cubic feet. Natural gas storage fundamentals are weak due to: 1) a compressed seasonal storage spread; 2) subdued market volatility; 3) increased storage capacity; 4) the surplus supply situation. However, we believe the sell-off is overdone, and that the current 8.3% yield provides an attractive entry point for a quality company whose fundamentals should improve over the next 12-18 months. We upgrade our rating to Buy from Neutral.

PNG is Well-Positioned PNG has contracted a high portion of storage at attractive rates: ~95% of its capacity for the 2011-12 storage season, ~80% for the 2012-13 season and ~50% for the 2013-14 season. These contracts have an average life of 3.5 years. PNG plans to increase 2012 capacity by ~23% by adding low-cost capacity that is attractive even in the current challenging environment.

Strong Financial Position Long-term debt is 25% of capitalization and adjusted EBITDA/interest is 19.0x. Subordinated units provide substantial protection for the current $1.38 common unit distribution which is forecast to be increased to $1.43 by year-end. PNG has an excellent management team and a strong sponsor in Plains All American Pipeline (PAA) with solid alignment of interest.

Valuation: Buy; Maintaining $22.50 Price Target Our DDM-derived price target, combined with its current 8.3% yield, provides a 41% total return potential.

Notes: Source: The content presented above reflects a front page summary of UBS Research content, UBS estimates based on a share price of US$16.40 on 12 Sep 2011 16:15 EDT

Nat Fuel Gas Rating: Buy Target: US$75.00 Price: US$56.41 RIC: NFG.N Prior: Unchanged Prior: Unchanged Mkt Cap: US$4.66bn BBG: NFG US

Gas Utilities Analyst: Ronald J. Barone Tel: +1-212-713 3848

With JV Catalyst Removed, A Show-me Story Analyst day provides an opportunity for a fresh review NFG’s September 9th analyst day provided an opportunity to speak with mgmt, get updates

on various E&P, Pipeline, and Utility developments, and revisit our growth and valuation forecasts. We believe NFG presents a secure and growing dividend with nearly unparalleled Marcellus exposure. While its stock remains undervalued, in our view, the company’s recent decision not to pursue a Marcellus JV removed a potentially significant valuation catalyst and transformed NFG into a ‘show me’ story which we believe must now prove up the value of its extensive acreage via successful drilling results.

Implied Marcellus value is depressed, but full development will take time We note that NFG’s current share price implies $2,000/acre for its 745,000 net acre Marcellus position, much less than the ~$6,000/acre median PV-implied price for Marcellus deals since Nov. 2008 and sharply lower than the ~$7,100/acre price implied by August’s NBL-CNX JV. While we recognize this wide acreage value disparity, we highlight that it will require a considerable period of time for NFG to drill up its estimated 5,000+ locations, particularly with plans to spud an average of 130 wells/year over its F2012-F2014 plan.

Management presents its 3-year plan; Additional leverage required At Friday’s meeting, mgmt detailed a plan to grow F2011-14 production at a ~41% CAGR, boost pipeline throughput at a ~20% CAGR, and maintain a 55-65% equity structure. With plans to outspend cash flow each year, more leverage is required.

Valuation: Maintain $75 SOP-derived price target We maintain our $75 SOP-derived price target and Buy rating on the shares. Notes:






UBS 12

Niska Gas Storage Rating: Neutral Target: US$13.00 Price: US$12.82 RIC: NKA.N Prior: Unchanged Prior: US$18.00 Mkt Cap: US$0.87bn BBG: NKA US

Pipelines Analyst: Ronald J. Barone Tel: +1-212-713 3848

Weak Fundamentals Persist; Neutral Weak Fundamentals Persist Niska owns and operates 3 natural gas storage facilities, including AECO Hub in Alberta; Wild Goose in CA; and Salt

Plains in OK. It also contracts storage capacity on Natural Gas Pipeline Co of America. Natural gas storage fundamentals remain weak due to: 1) a compressed seasonal storage spread; 2) subdued market volatility; 3) increased storage capacity; 4) the surplus supply situation.

Sponsor Aid Niska's private equity sponsor, Carlyle/Riverstone Funds, will invest the total distributions it expects to receive on its common and subordinated units for the next several quarters. The sponsor owns 16.3MM common and all of the 33.8MM subordinated units. This support increases Niska’s protection from debt covenant restrictions and maintains financial flexibility to continue its organic growth.

Two Organic Growth Projects Should Increase Storage Capacity 8.3% Niska is increasing capacity at AECO Hub by 2 Bcf and at Wild Goose by 15 Bcf. These low-cash expansions are expected to be completed by FYE11 and be accretive despite current unfavorable market conditions.

Valuation: Maintain Neutral Rating; Price Target Cut from $18 to $13 We maintain our Neutral rating given the well-above average yield. However, we are reducing our PT as distribution coverage is well-below average, sponsor support is necessary to maintain the distribution, and the growth outlook is bleak. We have lowered our forecast results to reflect NKA’s F1Q12 guidance update, which, along with an increased cost of equity reflecting greater business risk from difficult fundamental conditions, drives our PT change. Our DDM-derived $13 PT implies a 10.8% yield on our FY12e $1.40/unit distribution.


Standard Pacific Rating: Buy Target: US$4.50 Price: US$2.33 RIC: SPF.N Prior: Unchanged Prior: Unchanged Mkt Cap: US$0.60bn BBG: SPF US

Home Construction Analyst: David Goldberg Tel: +1-212-713 9427

Staying the Course CEO Transition Unlikely to Derail Strategy Last night, Standard Pacific announced that Scott Stowell will now assume day-to-day responsibilities &

become CEO in 1/12, upon Ken Campbell’s resignation. In our opinion, this was largely expected, as Mr. Campbell had already executed his plan to put the co on the right course and that future operational improvements will depend more on execution of this strategy and a turn in the broader housing market. Further, in light of Mr. Stowell’s extensive experience in the industry and at SPF (he joined 25 yrs ago), we expect the transition to be seamless.

Business Model Will Drive Outperformance As Conditions Recover Since the beginning of May, SPF has declined 39% vs the 34% avg decrease for the group and 15% drop in the S&P 500. In turn, it now trades at 1.0x tang BV. We continue to believe that the co’s differentiated approach—focusing on the move-up buyer and identifying opportunities for land acq at attractive prices, regardless of the stage of development—will drive outperformance. We maintain our Buy rating.

Opportunities Arise as the New Home Market Bottoms Although we acknowledge that recent macro indicators may suggest weaker near term economic trends, we believe fundamentals in the new home market are at—or near—a trough. While visibility for a turnaround remains limited, we believe current valuations for selective builders offer attractive buying opportunities with minimal downside and significant upside potential.

Valuation: $4.50 PT Based on 1.3x Our Trough BV Est. Our $4.50 PT is 1.3x our trough BV estimate, above the group average. Notes:





UBS 13

FINANCIALS American Capital Mtg Rating: Buy Target: US$21.00 Price: US$17.09 RIC: MTGE.O Prior: Not Rated Prior: Not Rated Mkt Cap: US$0.17bn BBG: MTGE US

Investment Services Analyst: Dean Choksi, CFA Tel: +1-212-713 2382

Actively Managed Hybrid Mortgage REIT Initiating coverage with a Buy rating and $21 price target American Capital Mortgage (MTGE) is a hybrid mortgage REIT investing in agency

mortgage-backed securities (MBS) and non-agency RMBS, as well as whole loans with leverage. It is externally managed by the same team that manages American Capital Agency (AGNC, not rated), a successful agency mortgage REIT utilizing an active asset selection and hedging strategy.

Attractive returns on agency carry trade; more risk in non-agency The steep yield curve and the Fed’s pledge to maintain the Fed Funds at 0-25bp through mid-2013 ensure a profitable agency MBS carry trade, particularly in a weak economy; 60% of capital is allocated to agency MBS. The non-agency strategy consists of two parts: 1) legacy securities; and 2) prime whole loans. The near-term opportunity is buying RMBS, while over the longer term, the strategy should shift to buying whole loans for securitization as the government sponsored enterprise’s (GSE’s) role in the mkt shrinks and the economics are more attractive.

3% dividend yield in 3Q rising to 19% by 1Q12, ex. potential capital gains We expect the dividend to increase to $0.80 by 1Q12, with potential upside depending on the level of capital gains.

Valuation: Multiple expansion as portfolio ramps; $21 PT 1.05x BV of $19.90 At a 15% discount to book value, we think shares are attractively valued for a largely agency portfolio and cash; the multiple should expand as the remaining capital is deployed and the dividend target is set. A hybrid REIT-like MTGE is best suited for investors looking for yield and a housing / economic recovery.

Notes:




UBS 14

HEALTHCARE Managed Care

Healthcare Providers Analyst: Justin Lake, CFA Tel: +1-212-713 2765

Updating MCO Price Targets Market realities drive Managed Care revaluation While continued modest cost trends leave favorable near-term Managed Care fundamentals, group

continues to be pressured by broader market weakness coupled with overhang via ongoing debt ceiling debate. MCOs valuation multiples now ~9x (representing 20% discount vs. S&P), down from 11x (16% discount to S&P) at the start of July (please see pages 2-3 for historical MCO multiples on both absolute and relative value basis).

Fundamentals remain solid, but stocks levered to multiple expansion We continue to be positively inclined on the MCO group given relatively modest exposure to potential broader economic slowdown vs. S&P in general (please see the Aug 16th UBS report “‘What if’ Grey or Black Skies Lie Ahead”, as well as our 8/17 Managed Care note “We See Modest Impact from Any Slowdown” for further color) with main headwinds on membership w/potential relief via lower med costs and ability to pass potential "Super-Committee" Medicare cuts thru to providers. As such, we cont to see favorable operating environment for plans in the near-term absent material med cost trend uptick (UBS checks showing no signs to date) and leave our 2011 / 2012 est. intact. That said, we take a more conservative view on target multiples and lower price targets across the group.

Lowering UBS price targets for Managed Care, estimates intact Table 1 below highlights our updated PT / target multiples for the Managed Care space, with pages 2-3 highlighting historical PE multiples for the group.




UBS 15

INDUSTRIALS Engineering & Construction

Heavy Construction Analyst: Steven Fisher, CFA Tel: +1-212-713 8634

Macro pressure creates headwinds UBS economists have reduced macro forecasts UBS has reduced macro forecasts for the US and Europe. UBS now expects US GDP growth of

1.6% in 2011 (was 2.6%) and 2.2% in 2012 (was 2.7%). In the Eurozone, UBS expects 1.8% in 2011 (unchanged) and 1.0% in 2012 (was 2.0%). Reducing earnings estimates; revenue and margin pressure expected We continue to expect a sluggish pace of growth, and we think a key

implication of the lack of faster growth is margin pressure, as industry capacity remains a bit loose. We reduce EPS estimates for SHAW, JEC, URS, WG, and TPC to reflect margin pressure. Other stocks may have mitigating factors (i.e. buybacks).

Micro level data points not all bad While the macro situation is creating headwinds, micro level data points are not all bad, and we provide some examples. ConocoPhillips’ refining spin off expects to spend $2-2.5b on refining in each of the next few years, which we believe is an increase from ~$1b annually under COP. JEC won a chemicals FEED for Aramco. Shaw was awarded a pipe fab contract for a new US manufacturing facility. The most negative data point we have seen is that Codelco indicated that some US and European customers have cancelled some copper orders due to macro uncertainty.

Valuations are not particularly demanding, but macro overhangs The E&C group is trading at 10x 2012 consensus estimates, and many stocks in the group are trading near the lower end of a typical historical range. The primary challenges are that estimates might still be too high and that the macro situation is keeping a lid on upside potential for the time being.


US Automakers

Automobile Manufacturers Analyst: Colin Langan, CFA Tel: +1-212-713 9949

UAW Contract Conference Call Takeways Changes could include upfront bonuses but no permanent wage increase Today, UBS hosted a call with Sean McAlinden on the UAW labor

contract negotiations. This contract expires on Sept 14th. GM will likely be the first to reach a deal (near deadline), followed by Chrysler (next week) and then Ford (end of the month). Major changes in the agreement likely include large upfront bonuses of ~$8,000/worker at GM/Chrysler and $10,000 at Ford. About $5,000 of the bonus reflects the reinstatement of ‘07 bonuses that were eliminated in bankruptcy. Importantly, workers will likely receive annual bonuses instead of wage increases.

Tier 2 utilization and wages are important for UAW and D3 Tier 2 employment explains ~64% of the $9/hour difference between Ford and Chrysler’s hourly wages. Moreover, ~33% of GM workers are near retirement, so the opportunity to replace these workers with lower cost Tier 2 workers is high. Sean expects this wage to increase from $14.50/hr today to $21-24/hr over the next 5 years. The UAW could trade Tier 2 constraints (ex. Orion) to keep plants open.

UAW likely wins healthcare cost debate UAW workers pay only 8% of their healthcare costs while nationally workers pay 33% and transplant workers pay 20%. Chrysler is fighting to increase the 8%; however the UAW is unlikely to agree to any healthcare cost concessions.

Reiterate Buy ratings on GM and Ford The expected large signing bonuses are disappointing and would negatively impact Q3 or Q4 EPS; however keeping the wages flat will ensure the long term viability of the D3 and the competitiveness of the UAW workforce.

Notes:


Commercial Aftermarket Monitor

Aerospace Analyst: David E. Strauss Tel: +1-212-713 6185

Initial Look at Q1 Flight Hours See flight hour growth decelerating in Q4-Q1 Our latest review of global airline schedules provides an initial look at Q1, which reflects decelerating

flight hour growth. Specifically, we forecast flight hours 4-5% higher in Q4-Q1, slower growth compared to 6-7% over the prior six quarters dating back to early 2010. Our Q1 2012 forecast reflects a roughly 2% seasonally-adjusted decline from peak levels in Q3.

Flight hour growth decelerating across all regions We see decelerating flight hour growth across all regions as capacity cuts announced by US airlines come through and Asia/Middle East comps become progressively more difficult. We forecast Q4-Q1 flight hours flat to slightly lower in North America with Europe up roughly 7% on continued LCC growth (even as Ryanair slows) and the rest of the world up 7-8%.

Flight hours well above prior peak, aftermarket still below While Q3 flight hours are 11% above the prior peak, aftermarket revenues are still below. So while flight hour growth is decelerating, we believe the aftermarket can grow at a faster rate. Most importantly, we see out-of-warranty flight hours, which are key to the aftermarket, growing faster than in-warranty (Chart 2).

Prefer aftermarket exposed names We continue to favor the aftermarket names over OE as we think increased utilization of out-of-warranty aircraft can still drive high single digit aftermarket growth through 1H 2012 despite slow capacity/economic growth. Our top picks are COL/GR/TDG.

Notes:






UBS 16

U.S. Aerospace & Defense

Aerospace Analyst: David E. Strauss Tel: +1-212-713 6185

Short Interest Update Short interest moves 3% higher 2H August On average, absolute short interest for our coverage group moved 3% higher in 2H August relative to

1H, while the stocks were up 4% on average over the same period. As a percentage of float, short interest for the group came in at 3.6% with aero at 3.6%, defense at 3.4% and multi-industry (TXT/UTX) at 4.1%.

Aero/defense short interest higher Short interest up 4% for our aero names in 2H Aug, while up 1% for defense and up 4% for UTX/TXT. SI increased most notably at PCP (+30%), BA (+21%) and LMT (+12%), while declining at GR (-30%) and NOC (-19%). As a % of total float, SI is highest at TGI/TXT (~8%); lowest at BA/GD/UTX, all around 1%.

Prefer aftermarket names We favor aftermarket names over OE as we think the aftermarket can continue to come through strong even with slowing economic/capacity growth on increased flying of out-of-warranty aircraft, while we view higher announced production rates at Airbus and BA as unsustainable. We prefer GR/COL/TDG.

Defense budget cuts worse than indicated Our analysis of the Deficit Reduction Act indicates the cuts to defense are larger and more front end loaded than widely understood. We believe the DoD budget will be reduced by roughly $500B in a best case scenario with the base budget flat to down in FY12-13 and modernization likely 5-10% lower. If the Super Committee can't agree to additional cuts, we estimate defense will be reduced by $1T with the FY13 budget likely 10% lower and modernization down even more.

Notes:




UBS 17

TECHNOLOGY NetLogic Microsystem Rating: Neutral Target: US$50.00 Price: US$48.12 RIC: NETL.O Prior: Buy Prior: US$44.00 Mkt Cap: US$3.30bn BBG: NETL US

Semiconductors Analyst: Steven Eliscu Tel: +1-415-352 5674

Raise PT to $50, Downgrade to Neutral Downgrade to a Neutral rating on valuation Based on the announced agreement for Broadcom to acquire NetLogic for $50/share and expectations

the deal will be completed essentially in its current form, we raise our price target to $50 and downgrade the stock to a Neutral rating, as it currently reflects a fair valuation.

Synergies uniquely valuable to Broadcom likely limit additional bids We believe NetLogic brings Broadcom unique synergies: 1) significant boost to its investments in the MIPS architecture, where the only other multicore vendor supporting such is Cavium, 2) solution for switching based on NetLogic’s control plane processor and Broadcom’s Trident switch fabric, which is potentially matched only by Intel with its recently acquired Fulcrum Microsystems switch fabric coupled with its Xeon processors, 3) search processors to complement Broadcom custom network processor for Alcatel-Lucent (~10% of NetLogic sales).

Overlap of the respective optical PHY businesses likely not a sticking point While there is overlap of the 10 Gbps optical physical layer (PHY) chip businesses, there will remain multiple direct competitors, including AppliedMicro, Cortina Systems and Vitesse along with indirect competitors, Altera and Xilinx (FPGAs can integrate optical PHY functionality). We also expect the optical segment to be overshadowed from 2012 by the likely much larger 10 Gbps copper PHY market (vendors include Broadcom, Marvell, Aquantia, PLX), as Intel moves the 10 Gbps PHY function onto the motherboard for its upcoming Romley server platform.

Valuation: Raise Price Target to $50, Downgrade to Neutral from Buy We raise our PT to $50 from $44 based on Broadcom’s acquisition price of NetLogic.


Atmel Rating: Buy Target: US$16.50 Price: US$9.05 RIC: ATML.O Prior: Unchanged Prior: US$18.00 Mkt Cap: US$4.13bn BBG: ATML US


Lower Estimates, PT on Slowing Macro. Reiterate Buy as Thesis Stays Solid Stay constructive but derisk for macro impact to Industrial/Consumer biz On read-throughs from our companies providing updates and

commentary on our recent bus tour as well as mixed macro data points, we lower our estimates and price target to $16.50 from $18.00, as we believe the combination of slowing orders and customers/channel pre-emptively destocking inventory in anticipation of macro weakness are the primary drivers. Nevertheless, Atmel remains among our top picks, and we reiterate our Buy rating, as we continue to believe Atmel is positioned to: 1) continue to lead the market in merchant touchscreen controllers, 2) gain share in the broader microcontroller market, 3) show operating leverage.

Positive view reinforced by new active stylus solution for next gen tablets Based on our recent industry checks, we believe Atmel has developed viable low-cost active stylus capability for tablets, which we believe will help sustain high-end touch-screen controller leadership in 2012. Even excluding stylus capability, which is likely to be initially a niche, we expect Atmel’s new E-series touch controllers to sustain its market position, even vs Cypress’s latest TrueTouch Gen 4 products.

Lower estimates on near-term macro headwinds, lower tablet sales We lower our 3Q11 sales/EPS estimates by 2%/5% to $482.3m/$0.18 and 2011 estimates by 2%/5% to $1,897m/$0.71. For 2012/13, we lower our sales estimates by 4% to $2,065m/$2,296m and EPS estimates by 7%/6% to $0.84/$0.99.

Valuation: Lower Price Target to $16.50, Reiterate Buy Rating We lower our DCF-based PT to $16.50 (20x our 2012 $0.84 EPS est) from $18. Notes:


Juniper Networks Rating: Neutral Target: US$24.00 Price: US$21.74 RIC: JNPR.N Prior: Unchanged Prior: Unchanged Mkt Cap: US$11.9bn BBG: JNPR US

Communications Technology Analyst: Nikos Theodosopoulos Tel: +1-212-713 3286

Innovation Day Thoughts Highlighting Innovation, No Financial Update, T4000 Most Promising Juniper emphasized its focus and strong position for capitalizing on growth

in the mobile internet and cloud computing. Although we did not hear anything requiring changes to our Juniper forecast at this time, we consider its T4000 launch as the most promising with relatively lower execution risk (4Q shipments). In the past Juniper seamlessly upgraded its core routers from the T640 to the T1600.

New Product Acceptance May Take Time We continue to believe a meaningful revenue ramp of Juniper’s new products, including the PTX, MobileNext and QFrabric, are likely to take time. Each of these products are likely to require a more lengthy customer sales cycle, in our view, than some of Juniper’s prior product launches, and may not be meaningful until 2Q or 3Q of 2012. More significant architectural decisions are required for PTX and QFrabric. MobileNext in the mobile core has a lengthened sales cycle.

Headcount Reduction Occurred This Past Week, But Modest In Size Juniper had a modest headcount reduction this past week, but that it was not material enough for the company to disclose publicly. In addition, Juniper still expects its headcount to be up by the end of 2011 vs. 2010, so it appears while there was a headcount reduction, it was more modest than we expected. Without more accelerated revenue growth, this likely lengthens the time for Juniper to achieve its long-term operating margin target of ~25%.

Valuation—Neutral Rating Our $24 price target is based on ~16x our CY12 EPS estimate of $1.53 ex opts. Notes:






UBS 18

Cypress Rating: Buy Target: US$22.00 Price: US$15.90 RIC: CY.O Prior: Unchanged Prior: US$26.00 Mkt Cap: US$2.68bn BBG: CY US


Lower Estimates, PT on Slower Macro, HP Device Exit. Expect Still Solid 2012 Growth Lower estimates, PT. Maintain Buy on solid +12% ‘12 sales, Nov catalysts On expectations the slowing macro will result in both OEM inventory

destocking pre-empting a downturn as well as slowing end demand, we lower estimates and PT to $22 from $26. Likely to have particular impact to Cypress are: 1) the slow consumer/computing sectors, which are likely to show muted 2H seasonality, 2) the loss of the HP WebOS device business to hit from 4Q ($5m+/qtr), 3) some delays in wireless infrastructure spend. We maintain Buy, as we expect solid +12% 2012 growth and believe its Nov analyst meeting could be a catalyst as it updates touch design wins and discloses a new business that could be material to valuation.

CY model well supported by multiple sales growth drivers and op leverage We lower our 2012 sales growth expectation to +12% from +20% but continue to view touchscreen controllers/microcontrollers and Emerging Tech businesses as key growth drivers. Even as we now model for slight y/y declines in SRAM and USB (assuming limited benefit from the USB 3.0 product cycle), stable gross margin and tight opex control should still drive 22% y/y non-GAAP EPS growth.

Lower estimates mainly in touchscreen controllers, USB and SRAM For 3Q, we lower our sales/non-GAAP EPS estimate by 3%/6% to $264.9m/$0.34 and for 2011, we lower estimates by 4%/8% to $1,006m/$1.20. For 2012/13, we lower sales 10%/8% to $1,132m/$1,305m and pf EPS by 16%/11% to $1.47/$1.74.

Valuation: Lower Price Target to $22, Maintain Buy Rating We lower our DCF-based PT to $22 (16x our $1.25 2012 pf EPS est) from $26. Notes:


Intersil Rating: Neutral Target: US$11.00 Price: US$10.66 RIC: ISIL.O Prior: Unchanged Prior: US$12.00 Mkt Cap: US$1.34bn BBG: ISIL US

Semiconductors Analyst: Uche Orji Tel: +1-212-713 4015

Intersil lowers 3Q outlook; Maintain Neutral, lower PT to $11 Intersil lowers 3Q outlook As expected, ISIL lowered its revenue outlook for 3Q to $184-$188m (down 12-10% Q/Q), from previous guidance of

$205-213m (down 2% to up 2%Q/Q). ISIL attributed the lowered outlook to broad-based weakness across end-markets and inventory adjustment. However, the company indicated that inventory is stabilizing and orders rate should improve going forward. We lower our estimates and reduce price target to $11.

Few signs of bottoming, but limited visibility on demand While the inventory in the channel should bottom out by the end of the quarter, we don’t see any significant demand catalysts to drive revenue, and therefore we remain cautious on the analog sector. We would like to see stabilization in macro indicators such as ISM and improved demand visibility before turning positive on the group.

Lowering estimates We lower 3Q Rev/EPS to $186m/10c, from $210m/16c. For 2011, we lower Rev/EPS to $784m/51c, from $836m/63c, and for 2012 to $766m/50c, from $882m/79c.

Valuation: Maintain Neutral, lower price target to $11 We maintain Neutral rating and lower price target to $11 from $12. Our $11 PT is DCF-based (WACC: 10.4%, g: 2%); equates to 22x 2012E EPS.

Notes: Source: The content presented above reflects a front page summary of UBS Research content, UBS estimates based on a share price of US$10.66 on 12 Sep 2011 18:42 EST

Diodes Inc. Rating: Neutral Target: US$20.00 Price: US$18.25 RIC: DIOD.O Prior: Unchanged Prior: US$22.00 Mkt Cap: US$0.83bn BBG: DIOD US

Semiconductors Analyst: Steven Chin Tel: +1-415-352 5675

Outlook Lowered on Persistent Softness Q3 revenue guidance unchanged but gross margin view lowered to 29.0% Diodes maintained its Sep ’11 quarter revenue outlook for a sales

range of $160-170m, or flat to down -6%. However, it lowered its gross margin view to 29.0% +/- 150bps vs the prior midpoint of 32.0% due to unfavourable pricing and sales mix as Diodes maintains fab utilization rates. We believe Diodes continues to execute well and remains nimble despite the challenging end market demand conditions.

Cost pressures from labor and metals expected to persist in medium term We expect Diodes’ design win pipeline, growing exposure to Asia consumers, and new standard logic products to help the company outperform peers on a relative basis and gain further share in discrete and standard analog. However, we believe the soft macro and rising manufacturing costs will continue to weigh on sentiment for the name. In addition to labor costs, Diodes’ ability to quickly move to copper from gold as a key chip packaging material will influence forward margin trends.

Lowering C11/12E EPS by -9%/-4% on lower gross margin view Our Q3 sales forecast is unchanged at $163m but GAAP EPS declines to $0.26 from $0.32 on lower gross margin view and partly offset by reduced tax rate. We also reduce our Q4 gross margin forecast and leads to C11 EPS declining -9% to $1.39. C11 sales are unchanged at $661m. C12 sales remain at $695m but we trim 1H gross margins, resulting in EPS declining -4% to $1.59.

Valuation: Lower Price Target to $20 from $22, Neutral rating Our new $20 DCF-based PT is equiv to 14x C11E EPS (11x non-GAAP) vs a historic range of 9-20x. We assume a WACC of 12.3% and terminal growth of 2%.

Notes:






UBS 19

IT Hardware

Computers Analyst: Maynard J. Um Tel: +1-212-713 3372

Short Interest (Aug 31) & Catalyst Update NYSE & NASDAQ Short Interest Summary for the period ended 08/31/11 Short interest increased 11.2% prd/prd for IT Hardware companies under

coverage while the market was up 1.2% in the prd. IBM (27.3%), NTAP (23.3%) & AAPL (20.9%) saw large increases while HPQ saw largest decrease at 6.4%. Catalysts include Intel Developer Conf., Microsoft Analyst day and RIMM earnings.

AAPL & IBM see large short interest increases AAPL SI increased 20.9% while stock was flattish. We believe a new iPhone, iCloud initiative and strong demand for iPads and Macs should drive a seasonally strong 2H11 & expect seamless CEO transition. With strong trends and at 12x our FY12 EPS est., we see valuation compelling. IBM stk was also flat during the prd with SI up 27.3% (up 10% and 13.3% in last 2 prd).

HPQ sees largest short interest decline; DELL’s SI increases HPQ SI was down 6.4% with stk declining 19.7% during the prd as HPQ lowered guidance and announced several strategic changes. HP’s challenges could take multiple quarters to resolve, in our view. Dell SI increased 8.1% in the prd as op. margin pressure and limited revenue growth (pruning of low-margin business) could potentially limit EPS upside near-term.

EMC short interest decreases while NTAP’s increases EMC’s SI was dn 5.8% and its coverage ratio remained high at 3.18 days. NTAP’s SI saw a large increase of 23.3%likely reflecting its cautious public and fin. svcs sectors spending with July orders slowing to half the level that of May. L-T, we expect NetApp to perform well given favorable secular trends in NAS market.

Notes:




UBS 20

TRANSPORTATION Swift Transportation Rating: Buy Target: US$13.50 Price: US$7.78 RIC: SWFT.N Prior: Unchanged Prior: Unchanged Mkt Cap: US$0.57bn BBG: SWFT US

Trucking Analyst: Rick Paterson Tel: +1-212-713 7944

No Bad News is Good News Management affirms Street estimates, sees solid Q3 volumes, pricing SWFT held a mid-quarter update call tonight and management’s

commentary should provide investors with a sigh of relief given the recent selloff in the shares. Trucking volumes will likely rise 4% y/y in Q3 with pricing coming in at +3-4% in 2H/2011. Management plans to dispose of tractors (~6% of truck count) and reduce capex spend in 2011 which will result in higher gains on sales in Q3.

Affirmation of consensus expectations is a moral victory SWFT’s comfort with Street numbers and reiteration of positive volume and pricing trends is a moral victory – no big upside surprise – but given the reaction (we’d say overreaction) in the stock in recent weeks the lack of bad news is good news. We’ll watch the fleet count as the easing of tractor growth is prudent in this uncertain climate, but the move also seems somewhat at odds with commentary that Swift’s customers remain very positive on a strong holiday season.

Top pick in the group SWFT remains our top pick in the space with the obvious caveat that all transport stocks would fall considerably in an economic worst case scenario. The risk/reward in SWFT looks very appealing given the attractive debt maturity profile (nothing large until 2016), limited near-term covenant hurdles, and valuation at just one turn over half that of the TL sector avg. (9x NTM EPS vs. 16x for the group ex-SWFT).

Valuation Our $13.50 target is based on 13x our forward EPS estimates. Notes:




UBS 21

UBS Key Calls - US Live Key Call Portfolio

Stock Name RIC Rating Price Target Date of call Current Price Analyst Apple Inc. AAPL.O Buy US$510 2-Jun-11 US$379.94 Maynard Um

Baker Hughes Inc. BHI.N Buy US$102 7-Jun-11 US$57.7 Angie Sedita

Cardinal Health, Inc. CAH.N Buy US$51 18-Jan-11 US$39.93 Steven Valiquette

Celgene Corporation CELG.O Buy US$71 9-Dec-10 US$60.32 Matthew Roden, PhD

CONSOL Energy, Inc. CNX.N Buy US$84 4-Aug-11 US$43.23 Shneur Gershuni, CFA

Deere & Co. DE.N Buy US$110 18-Jan-11 US$75.05 Henry Kirn, CFA

Dow Chemical DOW.N Buy US$40 21-Mar-11 US$25.76 Andrew Cash

Ford Motor Co. F.N Buy US$22 10-Jan-11 US$10.11 Colin Langan, CFA

General Electric Co. GE.N Buy US$20 10-Jan-11 US$15.01 Jason Feldman

Google Inc. GOOG.O Buy US$800 10-May-10 US$530.12 Brian Pitz

Joy Global Inc. JOYG.O Buy US$112 28-Feb-11 US$76.86 Henry Kirn, CFA

Prudential Financial Inc. PRU.N Buy US$77 19-Apr-10 US$46.8 Andrew Kligerman

Qualcomm Inc. QCOM.O Buy US$70 26-Apr-11 US$51.39 Parag Agarwal

SanDisk Corp. SNDK.O Buy US$62 21-Mar-11 US$40.02 Uche Orji

Source: Reuters, UBS. Prices as at market close on September 12, 2011.


UBS 22

Rating & PT Changes Key Rating and Price Target Changes: US

Company Name Directional Indicator/Rationale Reuters Code Current Share Price

New Rating New PT Prior

Rating Prior PT

AECOM Technology Corp. Reiterate Buy, lower PT ACM.N US$20.73 Buy US$29 Buy US$31

American Capital Mortgage Initiation of Coverage at Buy MTGE.O US$17.09 Buy US$21 Not Rated Not Rated

Atmel Corporation Reiterate Buy, lower PT ATML.O US$9.05 Buy US$16.5 Buy US$18

Cigna Corp. Reiterate Buy, lower PT CI.N US$43.68 Buy US$55 Buy US$59

Clear Channel Outdoor Initiation of Coverage at Neutral CCO.N US$10.39 Neutral US$11 Not Rated Not Rated

Coca-Cola Enterprises Upgrade to Buy, maintain PT CCE.N US$25.52 Buy US$30 Neutral US$30

Coventry Health Care Maintain Neutral, lower PT CVH.N US$31.8 Neutral US$34 Neutral US$35

Cypress Semiconductor Reiterate Buy, lower PT CY.O US$15.9 Buy US$22 Buy US$26

Dice Holdings Inc Maintain Neutral, lower PT DHX.N US$9.13 Neutral US$10 Neutral US$15

Diodes Incorporated Maintain Neutral, lower PT DIOD.O US$18.25 Neutral US$20 Neutral US$22

Health Net Inc. Maintain Neutral, lower PT HNT.N US$23.77 Neutral US$26 Neutral US$33

HealthSpring Inc. Reiterate Buy, lower PT HS.N US$36.72 Buy US$48 Buy US$52

Humana Inc. Reiterate Buy, lower PT HUM.N US$73.5 Buy US$87 Buy US$88

Inergy L.P. Upgrade to Buy, lower PT NRGY.N US$27.79 Buy US$31 Neutral US$36

Intersil Inc. Maintain Neutral, lower PT ISIL.O US$10.655 Neutral US$11 Neutral US$12

Jacobs Engineering Group, Inc. Maintain Neutral, lower PT JEC.N US$34.85 Neutral US$38 Neutral US$45

Lamar Advertising Initiation of Coverage at Sell LAMR.O US$18.26 Sell US$16.5 Not Rated Not Rated

Monster Worldwide Inc. Reiterate Buy, lower PT MWW.N US$8.09 Buy US$11 Buy US$18

NetLogic Microsystems Inc Downgrade to Neutral, increase PT NETL.O US$48.12 Neutral US$50 Buy US$44

Niska Gas Storage Partners LLC Maintain Neutral, lower PT NKA.N US$12.82 Neutral US$13 Neutral US$18

PAA Natural Gas Storage LP Upgrade to Buy, maintain PT PNG.N US$16.4 Buy US$22.5 Neutral US$22.5

Shaw Group Inc Reiterate Buy, lower PT SHAW.N US$23.22 Buy US$33 Buy US$37

Triple-S Management Corporation Maintain Neutral, lower PT GTS.N US$16.15 Neutral US$17.5 Neutral US$24

Tutor Perini Corp. Reiterate Buy, lower PT TPC.N US$13.32 Buy US$26 Buy US$28


UBS 23

UnitedHealth Group Reiterate Buy, lower PT UNH.N US$46.26 Buy US$58 Buy US$60

URS Corporation Maintain Neutral, lower PT URS.N US$31.69 Neutral US$35 Neutral US$38

WellPoint, Inc. Reiterate Buy, lower PT WLP.N US$63.38 Buy US$79 Buy US$90

Willbros Group, Inc. Maintain Neutral, lower PT WG.N US$5.91 Neutral US$6.5 Neutral US$9.25

Source: Reuters, UBS. Prices as at market close on September 12, 2011.


UBS 24

Markets, Events and Newsflow Today’s Company Events

Company Name Event Reuters code Rating PT Notes

Best Buy Earnings Release BBY.N Neutral US$26

Source: Reuters, UBS. Prices as at market close on September 12, 2011. Today’s Macroeconomic Events: US

Indicator Time (ET) UBS forecast Previous Consensus

Manpower Employment Survey (Q4)index 1:00 na na na

NFIB Index (Aug)index 8:30 na 89.9 na

Weekly ICSC Store Sales (Sep 10)wow 8:45 na na na

Redbook Store Sales (Sep 10)mom 9:55 na na na

Import Prices (Aug)mom 9:30 na 0.3% na

TIPP/IBD Optimism Index (Sep)index 11:00 na 35.8 na

Federal Budget (Aug)lvl 15:00 na na na

Source: Bloomberg, UBS

Today’s UBS Hosted Corporate Roadshow: Company Event Location Dell 1X meeting hosted by Maynard J. Um Europe / UK

El Paso Corporation 1X meeting hosted by Ronald J. Barone Midwest

Foot Locker, Inc. 1X meeting hosted by Michael Binetti Boston

NTELOS Holdings Corp 1X meeting hosted by Batya Levi Southeast

Questar Corp 1X meeting hosted by Christopher P. Sighinolfi Europe

Today’s UBS Hosted Fieldtrip:

Company Event Location Amazon UBS Fieldtrip West Coast

Today’s UBS Hosted Conference:

Company Event Location

None


UBS 25

Latest Market Movements: Country/Region Market Latest Price/Last Close 1-day % Change YTD % Change

Americas

United States Dow Jones 11061.1 0.63 -4.46

United States S&P 500 1162.3 0.70 -7.58

United States Nasdaq 2495.1 1.10 -5.95

United States S&P VIX 38.59 0.18

Europe

Europe FTSE Eurofirst300 885.8 -0.58 -21.03

Belgium BEL 20 2037.6 -0.75 -20.98

Germany DAX 5057.9 -0.28 -26.85

France CAC 2810.5 -1.55 -26.13

Italy MIB 30 13470.0 -0.03 -33.23

Netherlands AEX 265.9 -0.98 -25.02

Portugal PSI 20 5657.3 -2.38 -25.45

Spain IBEX 7603.5 -0.49 -22.88

Switzerland SMI 5320.2 0.32 -17.34

UK FTSE 100 5105.4 -0.47 -13.47

Asia

Hong Kong Hang Seng 19030.5 0.00 -17.39

India BSE Sensex 16490.5 -0.07 -19.59

Japan Nikkei 225 8616.6 0.95 -15.76

Source: UBS, Reuters. Indices in Americas as at market close on September 12, 2011. Indices in Europe and Asia as at 05:00 EDT on September 13, 2011

Latest FX Movements: Name Currency Latest Price/Last Close 1-day % Change 1-month % Change YTD % Change

Euro €/$ 1.367 0.16% -4.0% 2.1%

UK £/$ 1.586 0.17% -2.6% 1.6%

Canada CAD/$ 1.008 0.48% -0.5% 0.6%

Switzerland CHF/$ 1.135 0.33% -11.7% 6.1%

China Yuan/$ 0.157 0.00% 0.0% 3.2%

Brazil BRL/$ 0.587 -1.81% -5.4% -2.6%

India INR/$ 0.021 -1.56% -3.9% -5.3%

Mexico MXN/$ 0.078 -1.32% -4.3% -4.1%

Japan $/JPY 0.771 -0.50% 0.6% -5.0%

Australia AUD/$ 1.036 -0.51% 0.0% 1.2%

Source: UBS, Reuters. Prices as at market close on September 12, 2011


UBS 26

Latest Commodity Movements: Name Latest Price 1-day % Change 1-month % Change YTD % Change

Gold ($/oz) 1811.70 -0.09 5.65 30.05

Brent Crude spot, $/bbl 112.06 -0.17 7.32 24.11

WTI Crude spot, $bbl 88.45 0.29 - -

Natural Gas, $MMBTU 3.87 -0.33 -5.04 -6.16

Source: UBS, Reuters. Prices as at market close September 13, 2011.


UBS 27

UBS Conferences and Seminars For the week of 12th to 16th September

From To Event Location None

Upcoming UBS Conferences and Seminars From To Event Location 12-Sep-2011 13-Sep-2011 Global Transport Conference 2011 London 14-Sep-2011 15-Sep-2011 Global Paper and Forest Products Conference New York 19-Sep-2011 21-Sep-2011 Global Life Sciences Conference New York 27-Sep-2011 30-Sep-2011 Global Oil & Gas Conference London 28-Sep-2011 28-Sep-2011 UBS Business Development Company (BDC) Conference New York 15-Nov-2011 16-Nov-2011 Global Macro CTA & FX Conference 2011 Zurich 15-Nov-2011 17-Nov-2011 Global Technology and Services Conference New York 29-Nov-2011 01-Dec-2011 Global Real Estate CEO conference London

Recent events

From To Event Location 17-Aug-2011 17-Aug-2011 What If...Grey or Black Skies Lie Ahead? Conference Call 19-Aug-2011 19-Aug-2011 TV/Radio/Newspaper M&A Market Update Conference Call 19-Aug-2011 19-Aug-2011 Which Shade? Conference Call 22-Aug-2011 22-Aug-2011 Q2 UBS/Mercent eCommerce Update Conference Call

25-Aug-2011 25-Aug-2011 State of the Life Insurance Industry Update and Outlook with Moody’s Conference Call

25-Aug-2011 25-Aug-2011 MSFT: Top 10 Things To Watch for at BUILD Conference Conference Call *For further information on any of these events, please contact your UBS representative. Replay details may be available for recently concluded conference calls.

http://links.mkt2438.com/servlet/MailView?ms=MzcyNjUwNwS2&r=MTU0MDY0MTcwMDIS1&j=MjIwNzc4MjA4S0&mt=1&rt=0


UBS 28

Today’s UBS Event

ab Conference Call

Global Utilities Sector Strategy On this call we discuss our sector outlook for global utilities for 2011 H2; highlighting our regional and sub-sector tilts. Although we are cautious on the sector as a whole, we do think current markets will favour visibility and defensiveness; and that a portfolio of hand picked utility stocks from across regions has the potential to outperform falling markets. On this call we highlight a portfolio of utility stocks with a regional spread.

Speakers:

Per Lekander - UBS Co-Global Utilities & Infrastructure Strategist Head of European Utilities Research

Stephen Oldfield - UBS Co-Global Utilities & Infrastructure Strategist Head of Asia Utilities Research

Jim von Riesemann - USA Utilities Research Lilyanna Yang - Brazilian Utilities Research

Toshinori Ito - Japan Utilities Research David Leitch - Australia Utilities Research

Date & Time:

Tuesday, 13th September 12:30 London / 19:30 HK / 20:30 Tokyo / 21:30 Sydney / 07:30 NY

Dial-in details:

* International Dial-In Number + 6567239388 (Conference ID: 99615131)

Local Dial-In Number(s) Australia , Sydney: 0280640614 / China , Domestic: 4006988181 / China , Domestic: 4001200712

China , Domestic: 8008700811 / Hong Kong: 85225618854 / India , Mumbai: 912230985679 Japan , Domestic 0120938044

International Toll Free Dial-in Number(s): Australia - 1800148543 France – 0800912768 S.Korea - 003086511392 Russia - 81080020192012 Austria - 0800295717 Germany – 08001822967 Malaysia - 1800801678 South Africa - 0800995588 Belgium - 080071841 Hong - Kong – 800965084 Mexico - 0018005146734 Sweden - 020794030 Canada - 18775806574 India – 180030105460 Netherlands - 08000223241 Switzerland - 0800835856 Chile 12300208934 Indonesia – 001803657434 New Zealand 0800448207 Taiwan - 00801232425 China Netcom - 108006110137 Ireland – 1800556602 Norway - 80013022 Thailand - 001800656198 ChinaTelecom- 108003610157 Israel – 1809452550 Philippines - 180016510618 UK - 08000322281 Colombia - 018005181462 Italy – 800873907 Poland - 008001124235 United States - 18664052350 Denmark - 80886356 Japan – 00531653988 Portugal - 800819858


UBS 29

Today’s UBS Event

ab

Research Insight Conference Call

U.S. Life Insurance Industry Update with S&P

Host: Andrew Kligerman

Global Insurance Strategist and U.S. Life Insurance Analyst

Speaker: Kevin T. Ahern

Senior Director – Analytical Manager, Standard & Poor’s Matthew T. Carroll

Director, Standard & Poor’s

Date & Time: Tuesday, September 13, 2011 // 10:00 am ET

Dial-in Details:

Toll Free: 800-773-5134 Toll / Int’l: 212-231-2905

Code: 21538019

Replay Details: Toll Free: 800-633-8284 Toll / Int’l: 402-977-9140

Code: 21538019


UBS 30

Today’s UBS Event

ab

Expert Access Conference Call

Implications of Media Fragmentation

Host: John Janedis

UBS Media Analyst

Speaker: Brian Wieser

CMO, Simulmedia

Topic of Discussion • How can marketers accomplish reach goals in a fragmented world • Mix shifts between day parts to manage TV inflation rates • Solutions to the reach/frequency problem • Key drivers of media inflation • Winners and losers of fragmentation

Date & Time: Tuesday, September 13, 2011 // 11:00am ET

Dial-in Details:


Code: 21537526

Replay Details: Toll Free: 800-633-8284 Toll / Int’l: 402-977-9140

Code: 21537526


UBS 31

Today’s UBS Event

ab

Research Insight Conference Call

Latam Telco pay-TV Competition set to rise; Implications for DTV

Host:

Tomas Lajous - Latam Telco Analyst John Hodulik - US Telco Analyst

Leslie Mallon - Telco/Media Sector Specialist

Topic of Discussion

• New Bill (PLC 116) signed into law on Monday September 12th will enable traditional telco players to offer wired pay TV services in Brazil

• We believe as a result, competition is set to rise and that AMX will a primary beneficiary

• Implications to DTV; Latin America has been the key driver to DTV’s overall growth and now accounts for ~ 25% of total EBITDA (majority from Brazil).

Date & Time: Tuesday, September 13th, 2011 // 2:00 PM ET

Dial-in Details:


Code: 21538289

Replay Details: Toll Free: 800-633-8284

Toll / Int’l: 1-402-977-9140 Code: 21538289


UBS 32

Forthcoming UBS Event

ab

Expert Conference Call

Private Builder Conference Call Series: Phoenix

Host: David Goldberg

UBS Building & Building Products Analyst

Guest Speaker: Jim Belfiore

Belfiore Real Estate Consulting

Date & Time: Thursday, September 15, 2011 // 11:00am ET

Dial-in Details:

800-272-0419 or 303-223-2682 Confirmation Code: 21538327#

Replay Details:

800-633-8284 or 402-977-9140 Replay Code: 21538327#


UBS 33

Forthcoming UBS Event

ab

Expert Access Conference Call

US Small Cap Equities Outlook – Strategy and Trading

Host:

Albert Aguiar Small Cap Specialist

Speaker:

Chip Miller US Small Cap Strategist and Steven Roney, Head of US Small Cap Execution

Topic of Discussion

Small Cap Strategy and Trading – Perspectives and Outlook

Chip Miller, US Small Cap Strategist, will discuss the key headwinds for the small cap sector as we head into

year-end and provide a sector/industry framework for the current market. Steve Roney, Head of US Small Cap Execution, will discuss trading flow in small caps and discuss emerging

tactical trends in the space.

Date & Time: Tuesday, September 20, 2011 // 2:00pm ET

Dial-in Details:

Toll Free: 800-785-6380 Toll: 212-231-2908

Code: 21538023

Replay Details: Toll Free: 800-633-8284

Toll: 402-977-9140 Code: 21538023


UBS 34

Further Information

Morning Expresso – United States Welcome to the Morning Expresso, an early morning summary of the key ideas and issues presented from UBS for the day ahead. Its contents include:

- key items from UBS’ United States Morning Meeting

- highlighted recommendation and price target changes

- today’s anticipated company, sector and macro-economic catalysts from the US Contextual Diary

- company and client events, conferences and conference calls from UBS

- overnight global market, forex and commodity movements

Morning Expresso is designed to give you all that you ‘need to know’ each morning.

Data presented is accurate as at 06:00 EDT on Tuesday, September 13, 2011.

Contacts & Feedback For further details concerning today’s Morning Expresso – United States note, please visit www.ubs.com/investmentresearch or speak to your UBS contact. This note is not intended to be static and it will evolve over time. Feedback welcomed on email to

[email protected]

Statement of Risk

Forecasting earnings and corporate financial behavior is difficult because it is affected by a wide range of economic, financial, accounting and regulatory trends, as well as changes in tax policy.


UBS 35

Analyst Certification

Each research analyst primarily responsible for the content of this research report, in whole or in part, certifies that with respect to each security or issuer that the analyst covered in this report: (1) all of the views expressed accurately reflect his or her personal views about those securities or issuers and were prepared in an independent manner, including with respect to UBS, and (2) no part of his or her compensation was, is, or will be, directly or indirectly, related to the specific recommendations or views expressed by that research analyst in the research report.


UBS 36

Required Disclosures This report has been prepared by UBS Securities LLC, an affiliate of UBS AG. UBS AG, its subsidiaries, branches and affiliates are referred to herein as UBS.

For information on the ways in which UBS manages conflicts and maintains independence of its research product; historical performance information; and certain additional disclosures concerning UBS research recommendations, please visit www.ubs.com/disclosures. The figures contained in performance charts refer to the past; past performance is not a reliable indicator of future results. Additional information will be made available upon request. UBS Securities Co. Limited is licensed to conduct securities investment consultancy businesses by the China Securities Regulatory Commission.

UBS Investment Research: Global Equity Rating Allocations

UBS 12-Month Rating Rating Category Coverage1 IB Services2

Buy Buy 54% 39%Neutral Hold/Neutral 39% 35%Sell Sell 7% 14%UBS Short-Term Rating Rating Category Coverage3 IB Services4

Buy Buy less than 1% 33%Sell Sell less than 1% 25%

1:Percentage of companies under coverage globally within the 12-month rating category. 2:Percentage of companies within the 12-month rating category for which investment banking (IB) services were provided within the past 12 months. 3:Percentage of companies under coverage globally within the Short-Term rating category. 4:Percentage of companies within the Short-Term rating category for which investment banking (IB) services were provided within the past 12 months. Source: UBS. Rating allocations are as of 30 June 2011. UBS Investment Research: Global Equity Rating Definitions

UBS 12-Month Rating Definition Buy FSR is > 6% above the MRA. Neutral FSR is between -6% and 6% of the MRA. Sell FSR is > 6% below the MRA. UBS Short-Term Rating Definition

Buy Buy: Stock price expected to rise within three months from the time the rating was assigned because of a specific catalyst or event.

Sell Sell: Stock price expected to fall within three months from the time the rating was assigned because of a specific catalyst or event.


UBS 37

KEY DEFINITIONS Forecast Stock Return (FSR) is defined as expected percentage price appreciation plus gross dividend yield over the next 12 months. Market Return Assumption (MRA) is defined as the one-year local market interest rate plus 5% (a proxy for, and not a forecast of, the equity risk premium). Under Review (UR) Stocks may be flagged as UR by the analyst, indicating that the stock's price target and/or rating are subject to possible change in the near term, usually in response to an event that may affect the investment case or valuation. Short-Term Ratings reflect the expected near-term (up to three months) performance of the stock and do not reflect any change in the fundamental view or investment case. Equity Price Targets have an investment horizon of 12 months. EXCEPTIONS AND SPECIAL CASES UK and European Investment Fund ratings and definitions are: Buy: Positive on factors such as structure, management, performance record, discount; Neutral: Neutral on factors such as structure, management, performance record, discount; Sell: Negative on factors such as structure, management, performance record, discount. Core Banding Exceptions (CBE): Exceptions to the standard +/-6% bands may be granted by the Investment Review Committee (IRC). Factors considered by the IRC include the stock's volatility and the credit spread of the respective company's debt. As a result, stocks deemed to be very high or low risk may be subject to higher or lower bands as they relate to the rating. When such exceptions apply, they will be identified in the Company Disclosures table in the relevant research piece. Research analysts contributing to this report who are employed by any non-US affiliate of UBS Securities LLC are not registered/qualified as research analysts with the NASD and NYSE and therefore are not subject to the restrictions contained in the NASD and NYSE rules on communications with a subject company, public appearances, and trading securities held by a research analyst account. The name of each affiliate and analyst employed by that affiliate contributing to this report, if any, follows.


UBS 38

Company Disclosures

Company Name Reuters 12-mo rating Short-term rating Price Price date AECOM Technology Corp.1, 5, 16b ACM.N Buy N/A US$20.73 12 Sep 2011 American Capital Mortgage2, 4, 5 MTGE.O Buy N/A US$17.09 12 Sep 2011 Apple Inc.6c, 7, 13, 16b, 18a AAPL.O Buy N/A US$379.94 12 Sep 2011 Atmel Corporation4, 5, 6a, 6b, 6c, 7, 13,

16b ATML.O Buy N/A US$9.05 12 Sep 2011

Baker Hughes Inc.2, 4, 5, 6a, 6b, 6c, 7, 13,

16b BHI.N Buy N/A US$57.70 12 Sep 2011

Cardinal Health, Inc.2, 4, 6a, 6c, 7, 16b, 18b, 22 CAH.N Buy N/A US$39.93 12 Sep 2011

Carnival Corp.6c, 7, 14, 16b, 22 CCL.N Buy N/A US$31.51 12 Sep 2011 Celgene Corporation6c, 7, 16b CELG.O Buy N/A US$60.32 12 Sep 2011 China Mobile (HK) Ltd16a, 16b 0941.HK Neutral N/A HK$77.85 12 Sep 2011 Cigna Corp.2, 4, 5, 6a, 6b, 6c, 7, 16b, 22 CI.N Buy N/A US$43.68 12 Sep 2011 Clear Channel Outdoor16b CCO.N Not Rated N/A US$10.39 12 Sep 2011 Coca-Cola Enterprises16b CCE.N Buy N/A US$25.52 12 Sep 2011 CONSOL Energy, Inc.4, 5, 6a, 16b CNX.N Buy N/A US$43.23 12 Sep 2011 Coventry Health Care2, 4, 5, 6a, 6b, 6c, 7,

16b CVH.N Neutral N/A US$31.80 12 Sep 2011

Cypress Semiconductor2, 8, 16b CY.O Buy N/A US$15.90 12 Sep 2011 Deere & Co.16b, 22 DE.N Buy N/A US$75.05 12 Sep 2011 Dell Inc.2, 4, 6a, 6b, 6c, 7, 16b DELL.O Buy N/A US$14.19 12 Sep 2011 Dice Holdings Inc16b DHX.N Neutral N/A US$9.13 12 Sep 2011 Diodes Incorporated5, 16b, 20 DIOD.O Neutral (CBE) N/A US$18.25 12 Sep 2011 Dow Chemical5, 6a, 6b, 6c, 7, 13, 16b, 22 DOW.N Buy N/A US$25.76 12 Sep 2011 Ericsson16b ERICb.ST Buy N/A SKr65.80 12 Sep 2011 Expedia Inc.16b, 20 EXPE.O Neutral (CBE) N/A US$29.64 12 Sep 2011 Ford Motor Co.4, 6a, 6b, 6c, 7, 13, 14, 16b,

18c F.N Buy N/A US$10.11 12 Sep 2011

General Electric Co.4, 5, 6a, 6b, 6c, 7, 16b, 18g, 22 GE.N Buy N/A US$15.01 12 Sep 2011

General Motors Company4, 5, 6a, 6b, 6c, 7, 16b GM.N Buy N/A US$21.87 12 Sep 2011

Goodrich Corp.4, 6a, 6b, 6c, 7, 16b, 22 GR.N Buy N/A US$84.31 12 Sep 2011 Google Inc.2, 4, 5, 6a, 6b, 6c, 7, 16b, 18d GOOG.O Buy N/A US$530.12 12 Sep 2011 HCA Inc16b HCA.N Buy N/A US$18.40 12 Sep 2011 Health Net Inc.4, 6a, 16b HNT.N Neutral N/A US$23.77 12 Sep 2011 HealthSpring Inc.4, 6a, 16b HS.N Buy N/A US$36.72 12 Sep 2011 Hewlett-Packard Co.2, 4, 5, 6a, 6b, 6c, 7,

16b, 17, 22 HPQ.N Neutral N/A US$22.60 12 Sep 2011

HTC Corporation 2498.TW Buy N/A NT$810.00 09 Sep 2011 Humana Inc.6b, 7, 16b HUM.N Buy N/A US$73.50 12 Sep 2011 IBM Corp.2, 4, 5, 6a, 6b, 6c, 7, 16b, 18e IBM.N Neutral N/A US$162.42 12 Sep 2011 Inergy L.P.4, 6a, 16b, 19b NRGY.N Buy (CBE) N/A US$27.79 12 Sep 2011 Intersil Inc.16b ISIL.O Neutral N/A US$10.66 12 Sep 2011 Jacobs Engineering Group, Inc.16b JEC.N Neutral N/A US$34.85 12 Sep 2011 Joy Global Inc.3, 4, 6a, 13, 16b, 20 JOYG.O Buy (CBE) N/A US$76.86 12 Sep 2011 Juniper Networks5, 16b, 18h JNPR.N Neutral N/A US$21.74 12 Sep 2011 Lamar Advertising16b LAMR.O Not Rated N/A US$18.26 12 Sep 2011 Monster Worldwide Inc.16b MWW.N Buy N/A US$8.09 12 Sep 2011 NASDAQ OMX Group, Inc.4, 6a, 6b, 6c, 7, 16b NDAQ.O Buy N/A US$22.82 12 Sep 2011

National Fuel Gas Company16b NFG.N Buy N/A US$57.38 12 Sep 2011 NetApp Inc13, 16b NTAP.O Buy N/A US$36.30 12 Sep 2011 NetLogic Microsystems Inc16b, 19a NETL.O Neutral (CBE) N/A US$48.12 12 Sep 2011


UBS 39

Company Name Reuters 12-mo rating Short-term rating Price Price date Niska Gas Storage Partners LLC4,

6a, 16b NKA.N Neutral N/A US$12.82 12 Sep 2011

Nokia4, 5, 6a, 6b, 6c, 7, 13, 16b NOK1V.HE Neutral N/A €4.23 12 Sep 2011 Nucor Corp.16b NUE.N Neutral N/A US$32.95 12 Sep 2011 PAA Natural Gas Storage LP16b PNG.N Buy N/A US$16.40 12 Sep 2011 Priceline.com Inc16b, 20 PCLN.O Neutral (CBE) N/A US$528.87 12 Sep 2011 Prudential Financial Inc.2, 4, 5, 6a, 6b,

6c, 7, 16b, 22 PRU.N Buy N/A US$46.80 12 Sep 2011

Qualcomm Inc.16b, 18f QCOM.O Buy N/A US$51.39 12 Sep 2011 Rockwell Collins Inc.4, 5, 6a, 6b, 6c, 7, 8,

16b, 18i COL.N Buy N/A US$47.74 12 Sep 2011

Samsung Electronics16b, 22 005930.KS Buy N/A Won780,000 09 Sep 2011 SanDisk Corp.13, 16b, 20 SNDK.O Buy (CBE) N/A US$40.02 12 Sep 2011 Shaw Group Inc4, 6a, 6c, 7, 16b, 20 SHAW.N Buy (CBE) N/A US$23.22 12 Sep 2011 Southwest Airlines4, 6a, 6c, 7, 16b, 22 LUV.N Neutral N/A US$7.96 12 Sep 2011 Standard Pacific Corp.16b, 20 SPF.N Buy (CBE) N/A US$2.32 12 Sep 2011 Starbucks Corp.6a, 6b, 6c, 7, 13, 16b, 18j SBUX.O Buy N/A US$37.65 12 Sep 2011 Starwood Hotels & Resorts Worldwide, Inc13, 16b, 22 HOT.N Buy N/A US$40.64 12 Sep 2011

Steel Dynamics Inc.16b STLD.O Neutral N/A US$11.18 12 Sep 2011 Swift Transportation Co.2, 4, 6a, 16b SWFT.N Buy N/A US$7.78 12 Sep 2011 TransDigm Group Inc.2, 4, 6a, 6c, 7, 16b TDG.N Buy N/A US$85.65 12 Sep 2011 Triple-S Management Corporation16b GTS.N Neutral N/A US$16.15 12 Sep 2011

Tutor Perini Corp.5, 16b TPC.N Buy N/A US$13.32 12 Sep 2011 United Continental Holdings Inc5, 13, 16b, 18k, 20 UAL.N Buy (CBE) N/A US$17.96 12 Sep 2011

UnitedHealth Group2, 4, 5, 6a, 6b, 6c, 7, 16b UNH.N Buy N/A US$46.26 12 Sep 2011

URS Corporation4, 6a, 16b URS.N Neutral N/A US$31.69 12 Sep 2011 WellPoint, Inc.2, 4, 5, 6a, 6b, 6c, 7, 16b WLP.N Buy N/A US$63.38 12 Sep 2011 Willbros Group, Inc.4, 5, 6a, 16b WG.N Neutral N/A US$5.91 12 Sep 2011 ZTE Corporation16b 0763.HK Buy N/A HK$20.10 12 Sep 2011

Source: UBS. All prices as of local market close. Ratings in this table are the most current published ratings prior to this report. They may be more recent than the stock pricing date 1. UBS Securities LLC is acting as manager/co-manager, underwriter, placement or sales agent in regard to an offering of

securities of this company/entity or one of its affiliates. 2. UBS AG, its affiliates or subsidiaries has acted as manager/co-manager in the underwriting or placement of securities of

this company/entity or one of its affiliates within the past 12 months. 3. UBS Securities LLC is acting as advisor to Joy Global Inc on the announced acquisition of a stake in International Mining

Machinery. 4. Within the past 12 months, UBS AG, its affiliates or subsidiaries has received compensation for investment banking

services from this company/entity. 5. UBS AG, its affiliates or subsidiaries expect to receive or intend to seek compensation for investment banking services

from this company/entity within the next three months. 6a. This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and investment banking

services are being, or have been, provided. 6b. This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and non-investment

banking securities-related services are being, or have been, provided. 6c. This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and non-securities

services are being, or have been, provided. 7. Within the past 12 months, UBS Securities LLC has received compensation for products and services other than

investment banking services from this company/entity.


UBS 40

8. The equity analyst covering this company, a member of his or her team, or one of their household members has a long common stock position in this company.

13. UBS AG, its affiliates or subsidiaries beneficially owned 1% or more of a class of this company`s common equity securities as of last month`s end (or the prior month`s end if this report is dated less than 10 days after the most recent month`s end).

14. UBS Limited acts as broker to this company. 16a. UBS Securities (Hong Kong) Limited is a market maker in the HK-listed securities of this company. 16b. UBS Securities LLC makes a market in the securities and/or ADRs of this company. 17. UBS Limited is acting as joint financial advisor to Autonomy Corp Plc in respect of the announced recommended offer

from Hewlett Packard Co 18a. A U.S. based global equity strategist, a member of his team, or one of their household members has a long common

stock position in Apple, Inc. 18b. A U.S. based global equity strategist, a member of his team, or one of their household members has a long common

stock position in Cardinal Health, Inc. 18c. A U.S. based global equity strategist, a member of his team, or one of their household members has a long common

stock position in Ford Motor, Co. 18d. A U.S. based global equity strategist, a member of his team, or one of their household members has a long common

stock position in Google, Inc. 18e. A U.S. based global equity strategist, a member of his team, or one of their household members has a long common

stock position in International Business Machines. 18f. A U.S. based global equity strategist, a member of his team, or one of their household members has a long common

stock position in Qualcomm Inc. 18g. The U.S. equity strategist, a member of his team, or one of their household members has a long common stock position

in General Electric. 18h. The U.S. equity strategist, a member of his team, or one of their household members has a long common stock position

in Juniper Networks Inc. 18i. The U.S. equity strategist, a member of his team, or one of their household members has a long common stock position

in Rockwell Collins Inc. 18j. The U.S. equity strategist, a member of his team, or one of their household members has a long common stock position

in Starbucks Corp. 18k. UBS Securities LLC is acting as an advisor to Continental Airlines on its announced agreement to merge with UAL Corp. 19a. Because this company is an announced takeout candidate, UBS believes the security presents lower-than-normal risk.

We have widened its rating band to +6%/-10% compared with +6%/-6%, respectively, under the normal rating system. 19b. Because UBS believes this security presents lower-than-normal risk, its rating is deemed Buy if the FSR exceeds the

MRA by 5% and Sell if the FSR is more than 5% below the MRA (compared with 6% and 6%, respectively, under the normal rating system).

20. Because UBS believes this security presents significantly higher-than-normal risk, its rating is deemed Buy if the FSR exceeds the MRA by 10% (compared with 6% under the normal rating system).

22. UBS AG, its affiliates or subsidiaries held other significant financial interests in this company/entity as of last month`s end (or the prior month`s end if this report is dated less than 10 working days after the most recent month`s end).

Unless otherwise indicated, please refer to the Valuation and Risk sections within the body of this report. For a complete set of disclosure statements associated with the companies discussed in this report, including information on valuation and risk, please contact UBS Securities LLC, 1285 Avenue of Americas, New York, NY 10019, USA, Attention: Publishing Administration. Additional Prices: Amazon.com Inc, US$216.56 (12 Sep 2011); Best Buy Co. Inc., US$24.96 (12 Sep 2011); Foot Locker Inc., US$19.61 (12 Sep 2011); Source: UBS. All prices as of local market close.


UBS 41

Global Disclaimer This report has been prepared by UBS Securities LLC, an affiliate of UBS AG. UBS AG, its subsidiaries, branches and affiliates are referred to herein as UBS. In certain countries, UBS AG is referred to as UBS SA. This report is for distribution only under such circumstances as may be permitted by applicable law. Nothing in this report constitutes a representation that any investment strategy or recommendation contained herein is suitable or appropriate to a recipient’s individual circumstances or otherwise constitutes a personal recommendation. It is published solely for information purposes, it does not constitute an advertisement and is not to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments in any jurisdiction. No representation or warranty, either express or implied, is provided in relation to the accuracy, completeness or reliability of the information contained herein, except with respect to information concerning UBS AG, its subsidiaries and affiliates, nor is it intended to be a complete statement or summary of the securities, markets or developments referred to in the report. UBS does not undertake that investors will obtain profits, nor will it share with investors any investment profits nor accept any liability for any investment losses. Investments involve risks and investors should exercise prudence in making their investment decisions. The report should not be regarded by recipients as a substitute for the exercise of their own judgement. Past performance is not necessarily a guide to future performance. The value of any investment or income may go down as well as up and you may not get back the full amount invested. Any opinions expressed in this report are subject to change without notice and may differ or be contrary to opinions expressed by other business areas or groups of UBS as a result of using different assumptions and criteria. Research will initiate, update and cease coverage solely at the discretion of UBS Investment Bank Research Management. The analysis contained herein is based on numerous assumptions. Different assumptions could result in materially different results. The analyst(s) responsible for the preparation of this report may interact with trading desk personnel, sales personnel and other constituencies for the purpose of gathering, synthesizing and interpreting market information. UBS is under no obligation to update or keep current the information contained herein. UBS relies on information barriers to control the flow of information contained in one or more areas within UBS, into other areas, units, groups or affiliates of UBS. The compensation of the analyst who prepared this report is determined exclusively by research management and senior management (not including investment banking). Analyst compensation is not based on investment banking revenues, however, compensation may relate to the revenues of UBS Investment Bank as a whole, of which investment banking, sales and trading are a part. The securities described herein may not be eligible for sale in all jurisdictions or to certain categories of investors. Options, derivative products and futures are not suitable for all investors, and trading in these instruments is considered risky. Mortgage and asset-backed securities may involve a high degree of risk and may be highly volatile in response to fluctuations in interest rates and other market conditions. Past performance is not necessarily indicative of future results. Foreign currency rates of exchange may adversely affect the value, price or income of any security or related instrument mentioned in this report. For investment advice, trade execution or other enquiries, clients should contact their local sales representative. Neither UBS nor any of its affiliates, nor any of UBS' or any of its affiliates, directors, employees or agents accepts any liability for any loss or damage arising out of the use of all or any part of this report. For financial instruments admitted to trading on an EU regulated market: UBS AG, its affiliates or subsidiaries (excluding UBS Securities LLC and/or UBS Capital Markets LP) acts as a market maker or liquidity provider (in accordance with the interpretation of these terms in the UK) in the financial instruments of the issuer save that where the activity of liquidity provider is carried out in accordance with the definition given to it by the laws and regulations of any other EU jurisdictions, such information is separately disclosed in this research report. UBS and its affiliates and employees may have long or short positions, trade as principal and buy and sell in instruments or derivatives identified herein. Any prices stated in this report are for information purposes only and do not represent valuations for individual securities or other instruments. There is no representation that any transaction can or could have been effected at those prices and any prices do not necessarily reflect UBS's internal books and records or theoretical model-based valuations and may be based on certain assumptions. Different assumptions, by UBS or any other source, may yield substantially different results. United Kingdom and the rest of Europe: Except as otherwise specified herein, this material is communicated by UBS Limited, a subsidiary of UBS AG, to persons who are eligible counterparties or professional clients and is only available to such persons. The information contained herein does not apply to, and should not be relied upon by, retail clients. UBS Limited is authorised and regulated by the Financial Services Authority (FSA). UBS research complies with all the FSA requirements and laws concerning disclosures and these are indicated on the research where applicable. France: Prepared by UBS Limited and distributed by UBS Limited and UBS Securities France SA. UBS Securities France S.A. is regulated by the Autorité des Marchés Financiers (AMF). Where an analyst of UBS Securities France S.A. has contributed to this report, the report is also deemed to have been prepared by UBS Securities France S.A. Germany: Prepared by UBS Limited and distributed by UBS Limited and UBS Deutschland AG. UBS Deutschland AG is regulated by the Bundesanstalt fur Finanzdienstleistungsaufsicht (BaFin). Spain: Prepared by UBS Limited and distributed by UBS Limited and UBS Securities España SV, SA. UBS Securities España SV, SA is regulated by the Comisión Nacional del Mercado de Valores (CNMV). Turkey: Prepared by UBS Menkul Degerler AS on behalf of and distributed by UBS Limited. Russia: Prepared and distributed by UBS Securities CJSC. Switzerland: Distributed by UBS AG to persons who are institutional investors only. Italy: Prepared by UBS Limited and distributed by UBS Limited and UBS Italia Sim S.p.A.. UBS Italia Sim S.p.A. is regulated by the Bank of Italy and by the Commissione Nazionale per le Società e la Borsa (CONSOB). Where an analyst of UBS Italia Sim S.p.A. has contributed to this report, the report is also deemed to have been prepared by UBS Italia Sim S.p.A.. South Africa: UBS South Africa (Pty) Limited (Registration No. 1995/011140/07) is a member of the JSE Limited, the South African Futures Exchange and the Bond Exchange of South Africa. UBS South Africa (Pty) Limited is an authorised Financial Services Provider. Details of its postal and physical address and a list of its directors are available on request or may be accessed at http:www.ubs.co.za. United States: Distributed to US persons by either UBS Securities LLC or by UBS Financial Services Inc., subsidiaries of UBS AG; or by a group, subsidiary or affiliate of UBS AG that is not registered as a US broker-dealer (a 'non-US affiliate'), to major US institutional investors only. UBS Securities LLC or UBS Financial Services Inc. accepts responsibility for the content of a report prepared by another non-US affiliate when distributed to US persons by UBS Securities LLC or UBS Financial Services Inc. All transactions by a US person in the securities mentioned in this report must be effected through UBS Securities LLC or UBS Financial Services Inc., and not through a non-US affiliate. Canada: Distributed by UBS Securities Canada Inc., a subsidiary of UBS AG and a member of the principal Canadian stock exchanges & CIPF. A statement of its financial condition and a list of its directors and senior officers will be provided upon request. Hong Kong: Distributed by UBS Securities Asia Limited. Singapore: Distributed by UBS Securities Pte. Ltd [mica (p) 039/11/2009 and Co. Reg. No.: 198500648C] or UBS AG, Singapore Branch. Please contact UBS Securities Pte Ltd, an exempt financial advisor under the Singapore Financial Advisers Act (Cap. 110); or UBS AG Singapore branch, an exempt financial adviser under the Singapore Financial Advisers Act (Cap. 110) and a wholesale bank licensed under the Singapore Banking Act (Cap. 19) regulated by the Monetary Authority of Singapore, in respect of any matters arising from, or in connection with, the analysis or report. The recipient of this report represent and warrant that they are accredited and institutional investors as defined in the Securities and Futures Act (Cap. 289). Japan: Distributed by UBS Securities Japan Ltd to institutional investors only. Where this report has been prepared by UBS Securities Japan Ltd, UBS Securities Japan Ltd is the author, publisher and distributor of the report. Australia: Distributed by UBS AG (Holder of Australian Financial Services License No. 231087) and UBS Securities Australia Ltd (Holder of Australian Financial Services License No. 231098) only to 'Wholesale' clients as defined by s761G of the Corporations Act 2001. New Zealand: Distributed by UBS New Zealand Ltd. An investment adviser and investment broker disclosure statement is available on request and free of charge by writing to PO Box 45, Auckland, NZ. Dubai: The research prepared and distributed by UBS AG Dubai Branch, is intended for Professional Clients only and is not for further distribution within the United Arab Emirates. Korea: Distributed in Korea by UBS Securities Pte. Ltd., Seoul Branch. This report may have been edited or contributed to from time to time by affiliates of UBS Securities Pte. Ltd., Seoul Branch. Malaysia: This material is authorized to be distributed in Malaysia by UBS Securities Malaysia Sdn. Bhd (253825-x).India : Prepared by UBS Securities India Private Ltd. 2/F,2 North Avenue, Maker Maxity, Bandra Kurla Complex, Bandra (East), Mumbai (India) 400051. Phone: +912261556000 SEBI Registration Numbers: NSE (Capital Market Segment): INB230951431 , NSE (F&O Segment) INF230951431, BSE (Capital Market Segment) INB010951437. The disclosures contained in research reports produced by UBS Limited shall be governed by and construed in accordance with English law. UBS specifically prohibits the redistribution of this material in whole or in part without the written permission of UBS and UBS accepts no liability whatsoever for the actions of third parties in this respect. Images may depict objects or elements which are protected by third party copyright, trademarks and other intellectual property rights. © UBS 2011. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.

ab

financial pacific - economic insights by george magnus (third party)

Business

cce shares

price target

macro concerns

ubs limited

ubs estimates

ubs commentary

cce ussoft drinks analyst

share price of us